In 2016, the Ministry of Health of the Russian Federation established a cluster for direct innovative development by creating a special federal centre – the Centre for Strategic Development, which collects and analyses information, compiles databases of competent specialists in each of our country’s 85 regions and across all sectors. The development of this cluster allowed us to move on to new organizational mechanisms — Veronika Skvortsova, Minister of Health of the Russian Federation.
The ‘Pharma 2030’ programme includes the most modern aspects: vaccines, biomedical cell products, gene therapy drugs, medical industry. <...> This is one of the most promising programmes. Both the sector and the businesses are waiting for it and fully support it — Alexey Martynov, President, Association of Biomedical Cellular Products Manufacturers.
Basically, today we have agreed that starting next year we will have a unified tool for financing drug research projects, which will allow us to give such subsidies upfront, so that we could pay advances to companies. <...> Together with RVC we are creating a venture capital fund to finance early development, risky development and long-term development. <...> We could consider financing part of the projects at early stages through venture capital instruments — Sergey Tsyb, First Deputy Minister of Industry and Trade of the Russian Federation .
If our smallest companies which are at pre-clinical research stages, at the early phases, somehow get the support from industrial companies, through acquisitions too, that would create more incentive to turn the inventions of our scientists into medicines — Alexey Repik, Chairman, Russian-Japanese Business Council; President, Delovaya Rossiya (Business Russia); Chairman of the Board, Group R-Pharm .
We are a big country; our logistics is complicated. We are talking about 5,000 patients. How do we build a centralized cell treatment centre for the patients? We need to understand that the fastest way is to help businesses that already have patients. Our government centres must help businesses to create such technologies. That is the only path towards practical implementation — Dmitry Morozov, General Director, BIOCAD.
The Roscongress Foundation is a socially oriented non-financial development institution and a major organizer of nationwide and international conventions; exhibitions; and business, public, youth, sporting, and cultural events. It was established in pursuance of a decision by the President of the Russian Federation.
The Foundation was established in 2007 with the aim of facilitating the development of Russia’s economic potential, promoting its national interests, and strengthening the country’s image. One of the roles of the Foundation is to comprehensively evaluate, analyse, and cover issues on the Russian and global economic agendas. It also offers administrative services, provides promotional support for business projects and attracting investment, helps foster social entrepreneurship and charitable initiatives.
Each year, the Foundation’s events draw participants from 208 countries and territories, with more than 15,000 media representatives working on-site at Roscongress’ various venues. The Foundation benefits from analytical and professional expertise provided by 5,000 people working in Russia and abroad.
The Foundation works alongside various UN departments and other international organizations, and is building multi-format cooperation with 180 economic partners, including industrialists’ and entrepreneurs’ unions, financial, trade, and business associations from 81 countries worldwide, and 186 Russian public organizations, federal and legislative agencies, and federal subjects.
The Roscongress Foundation has Telegram channels in Russian t.me/Roscongress, English – t.me/RoscongressDirect, Spanish – t.me/RoscongressEsp and Arabic t.me/RosCongressArabic. Official website and Information and Analytical System of the Roscongress Foundation:roscongress.org.